OTC · PKBFF
PeakBirch Commerce Inc.
$0.00$0.00 (0.0%)
PeakBirch Commerce Inc.: Healthcare · Medical - Pharmaceuticals.
Loading market information…
CNQ · WBIO.CN · CAD
Stock price, earnings
Quote as of Feb 20, 2025, 10:23 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
WPD Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow WPD Pharmaceuticals Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
PeakBirch Commerce Inc.: Healthcare · Medical - Pharmaceuticals.
CA$0.08+CA$0.02 (+23.08%)
Restart Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 40.74% below the high.
CA$0.07-CA$0.01 (-7.14%)
Ultrobotix Ltd.’s quoted price sits in the lower half of its reported 52-week range, 85.56% below the high.
$0.01$0.00 (0.0%)
ChitogenX Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Biocure Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.01CA$0.00 (0.0%)
Albert Labs International Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
CA$0.07CA$0.00 (0.0%)
Nirvana Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.0% below the high.
$0.00$0.00 (0.0%)
NanoSphere Health Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.94% below the high.
